Craft

AXIM Biotechnologies

Stock Price

$0

2024-04-29

Market Capitalization

$3.8 M

2024-04-29

Revenue

$39.5 K

FY, 2023

AXIM Biotechnologies Summary

Company Summary

Overview
AXIM Biotechnologies is a biotechnology company working on the treatment of pain, spasticity, anxiety, and other medical disorders. It focuses on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products.
Type
Public
Status
Active
Founded
2010
HQ
New York, NY, US | view all locations
Website
http://aximbiotech.com/
Cybersecurity rating
Sectors

Key People

  • John W. Huemoeller

    John W. Huemoeller, Chief Executive Officer, Director

    • George E. Anastassov

      George E. Anastassov, Founder, Chairman of the Board

      • Lekhram Changoer

        Lekhram Changoer, Chief Technology Officer, Director

        • Philip A. Van Damme

          Philip A. Van Damme, Chief Medical Officer, Board Member

        Operating MetricsView all

        Patent Applications

        13
        8.3%

        Q3, 2019

        Patents Licensed

        2
        100.0%

        Q3, 2019

        Trademark Applications

        28
        3.7%

        Q3, 2019

        LocationsView all

        2 locations detected

        • New York, NY HQ

          United States

          45 Rockefeller Plaza 20th fl

        • San Diego, CA

          United States

          6191 Cornerstone Ct E #114

        AXIM Biotechnologies Financials

        Summary Financials

        Revenue (FY, 2023)
        $39.5K
        Net income (FY, 2023)
        ($8.1M)
        Cash (FY, 2023)
        $156.5K
        EBIT (FY, 2023)
        ($2.8M)

        Footer menu